Paper Details

  1. Home
  2. Paper Details

Anticholinergic Drugs Interact With Neuroprotective Chaperone L-PGDS and Modulate Cytotoxicity of Aβ Amyloids.

Author: LowKimberly Jia Yi, PervushinKonstantin, PhillipsMargaret

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study investigated the potential interactions between two anticholinergic drugs (chlorpheniramine and trazodone) and the neuroprotective amyloid-beta chaperone, L-PGDS. The study found that both drugs bind to L-PGDS and can alter the morphology of amyloid-beta fibrils, potentially increasing their toxicity. These findings suggest a possible link between anticholinergic drugs and the development of Alzheimer's disease.
Paper Details　
Original Abstract of the Article :
Anticholinergic drugs can be used as a treatment for many diseases. However, anticholinergic drugs are also known for their cognition-related side effects. Recently, there has been an increasing number of reports indicating a positive association between exposure to anticholinergic drugs and Alzheim...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300299/

データ提供：米国国立医学図書館（NLM）

Anticholinergic Drugs and Alzheimer's Disease

This research ventures into the complex and often mysterious world of Alzheimer's disease. Imagine the brain as a bustling desert city, with intricate pathways and bustling marketplaces. This study explores the potential link between anticholinergic drugs, common medications used to treat various conditions, and the development of Alzheimer's disease. It's like observing the impact of a sudden sandstorm on this desert city, exploring the potential for long-term damage.

Anticholinergic Drugs May Increase Risk of Alzheimer's

The researchers found that anticholinergic drugs can interact with a crucial brain protein called L-PGDS, potentially hindering its ability to protect the brain from damage. This interaction could lead to the formation of harmful amyloid beta-peptide (Aβ) fibrils, which are like harmful sandstorms in the brain. The study also found that these altered fibrils can be more toxic to brain cells, potentially contributing to the progression of Alzheimer's disease.

Navigating the Desert of Alzheimer's

This research offers valuable insight into the potential risks associated with anticholinergic drugs. It suggests that these drugs, while effective for treating other conditions, might increase the risk of developing Alzheimer's disease. It's important to consult with a doctor to understand the potential risks and benefits of these medications, especially for individuals with a family history of Alzheimer's disease.

Dr. Camel's Conclusion

This research delves into the delicate and complex landscape of the brain, a vast and intricate desert city. The study explores the potential link between anticholinergic drugs and Alzheimer's disease, highlighting the importance of understanding the potential impact of medications on brain health.
Date :
  1. Date Completed n.d.
  2. Date Revised 2020-09-28
Further Info :

Pubmed ID

32595501

DOI: Digital Object Identifier

PMC7300299

Related Literature

Article Analysis
・Side Effects of chlorpheniramine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.